Top Markets
Coin of the day
Crescent Biopharma, Inc. Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

CBIO
株式のランク #11763
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and... Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
株価
$17.81
最終同期: 2026-08-28
時価総額
$661.63M
変化(1日)
0.30%
変化(1年)
23.70%
US
取引 Crescent Biopharma, Inc. (CBIO)

カテゴリー

Crescent Biopharma, Inc.(CBIO)のEPS
2026 時点のEPS TTM: 0
Crescent Biopharma, Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Crescent Biopharma, Inc.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -
US
$27.74 -
NL
$-5.29 -
AU
$-7.98 -
US
- -
CH